The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Procalcitonin
Abstract
Procalcitonin (PCT) is the 116 amino acid precursor of the hormone calcitonin, produced by the C cells of the thyroid. Its synthesis is upregulated in bacterial infection and downregulated by viral infection. Consequently, with the increasing development of antibiotic resistance, interest has focused on the ability of this marker to not only diagnose infection but to tailor antibiotic treatment and help reduce the development of antibiotic resistance. The value of PCT depends on the specific clinical situation and pretest probability of disease. This article discusses the role of PCT in these different situations, namely primary care, the emergency department and the intensive care unit. The true cost effectiveness of this test remains difficult to prove as evidence for the potential impact of using PCT on slowing the development of bacterial resistance remains largely circumstantial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under normal physiological conditions, the expression and processing of CALCA mRNA into the form that encodes procalcitonin is mostly restricted to C cells of the thyroid, where the precursor protein is quickly cleaved to generate mature calcitonin.The concentration of procalcitonin in the circulation in these conditions is very low (63).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [63]
Citations
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis.
Wacker, C., Prkno, A., Brunkhorst, F. M., & Schlattmann, P. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70323-7 · Cited by 1,198
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
Tang, B. M., Eslick, G. D., Craig, J. C., & McLean, A. S. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70052-x · Cited by 851
Uzzan, B., Cohen, R., Nicolas, P., Cucherat, M., & Perret, G.-Y. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000226413.54364.36 · Cited by 738
Update on Procalcitonin Measurements
Meisner, M. (2014) · Annals of Laboratory Medicine · doi:10.3343/alm.2014.34.4.263 · Cited by 395
Schuetz, P. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.318 · Cited by 386 · cited 1×
“Guidance on the interpretation of PCT results is largely based on recommendations by Schuetz et al.11 Optimal cut-offs for PCT depend on the clinical situations, which dictates the pretest probability of disease (table 2).”
MethodJensen, J. U., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Thornberg, K. J., Løken, J., Steensen, M., Fox, Z., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e8791 · Cited by 356
Thompson, M., Van den Bruel, A., Verbakel, J., Lakhanpaul, M., Haj-Hassan, T., Stevens, R., Moll, H., Buntinx, F., Berger, M., Aertgeerts, B., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16150 · Cited by 324
Briel, M., Schuetz, P., Mueller, B., Young, J., Schild, U., Nusbaumer, C., Périat, P., Bucher, H. C., & Christ-Crain, M. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.18.2000 · Cited by 321
Linscheid, P., Seboek, D., Schaer, D. J., Zulewski, H., Keller, U., & Müller, B. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000134404.63292.71 · Cited by 315
Schuetz, P., Briel, M., Christ-Crain, M., Stolz, D., Bouadma, L., Wolff, M., Luyt, C.-E., Chastre, J., Tubach, F., Kristoffersen, K. B., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis464 · Cited by 280
Prkno, A., Wacker, C., Brunkhorst, F. M., & Schlattmann, P. (2013) · Critical Care · doi:10.1186/cc13157 · Cited by 260
van Vugt, S. F., Broekhuizen, B. D. L., Lammens, C., Zuithoff, N. P. A., de Jong, P. A., Coenen, S., Ieven, M., Butler, C. C., Goossens, H., Little, P., et al. (2013) · BMJ · doi:10.1136/bmj.f2450 · Cited by 243
Biomarkers for pediatric sepsis and septic shock
Standage, S. W., & Wong, H. R. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.154 · Cited by 198
Henriquez-Camacho, C., & Losa, J. (2014) · BioMed Research International · doi:10.1155/2014/547818 · Cited by 194
Procalcitonin as a Marker for the Detection of Bacteremia and Sepsis in the Emergency Department
Riedel, S., Melendez, J. H., An, A. T., Rosenbaum, J. E., & Zenilman, J. M. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp1mfyinqlecv2 · Cited by 183
Charles, P. E., Ladoire, S., Aho, S., Quenot, J.-P., Doise, J.-M., Prin, S., Olsson, N.-O., & Blettery, B. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-38 · Cited by 180
Dusemund, F. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.770 · Cited by 167
Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection
Burkhardt, O., Ewig, S., Haagen, U., Giersdorf, S., Hartmann, O., Wegscheider, K., Hummers-Pradier, E., & Welte, T. (2010) · European Respiratory Journal · doi:10.1183/09031936.00163309 · Cited by 160
Procalcitonin for guidance of antibiotic therapy
Schüetz, P., Albrich, W. C., Christ‐Crain, M., Chastre, J. E., & Müeller, B. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.25 · Cited by 158
the CAPNETZ study group, Krüger, S., Ewig, S., Papassotiriou, J., Kunde, J., Marre, R., von Baum, H., Suttor, N., & Welte, T. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-65 · Cited by 146
Kristoffersen, K. B., Søgaard, O. S., Wejse, C. M., Black, F. T., Greve, T., Tarp, B., Storgaard, M., & Sodemann, M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02709.x · Cited by 133
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schüetz, P., Müller-Stich, B. P., Christ‐Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J. E., Tubach, F., et al. (2013) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.1927 · Cited by 132
Baer, G., Baumann, P., Buettcher, M., Heininger, U., Berthet, G., Schäfer, J., Bucher, H. C., Trachsel, D., Schneider, J., Gambon, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068419 · Cited by 129
Turner, D., Hammerman, C., Rudensky, B., Schlesinger, Y., Goia, C., & Schimmel, M. S. (2006) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2005.085449 · Cited by 127
Diagnostic and Prognostic Role of Procalcitonin in Infections
Hatzistilianou, M. N. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.181 · Cited by 126
Holm, A., Pedersen, S. S., Nexoe, J., Obel, N., Nielsen, L. P., Koldkjær, O. G., & Pedersen, C. (2007) · PubMed · Cited by 117
Agarwal, R. K., & Schwartz, D. N. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir408 · Cited by 117
Höhn, A., Schröder, S., Gehrt, A., Bernhardt, K., Bein, B., Wegscheider, K., & Hochreiter, M. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-158 · Cited by 100
Mann, E. A., Wood, G. L., & Wade, C. E. (2010) · Burns · doi:10.1016/j.burns.2010.04.013 · Cited by 99
Deliberato, R. O., Marra, A. R., Sanches, P. R., Dalla Valle Martino, M., dos Santos Ferreira, C. E., Pasternak, J., Paes, A. T., Pinto, L. M., dos Santos, O. F. P., & Edmond, M. B. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.03.027 · Cited by 93
Schüetz, P., BALK, R. A., Briel, M., Kutz, A., Christ‐Crain, M., Stolz, D., Bouadma, L., Wolff, M., Kristoffersen, K. B., Long, W., et al. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-1015 · Cited by 89
Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission
Sastre, J. B. L., Solís, D. P., Serradilla, V. R., Colomer, B. F., & Cotallo, G. D. C. (2007) · BMC Pediatrics · doi:10.1186/1471-2431-7-9 · Cited by 73
Haeusler, G. M., Carlesse, F. A. D. M. C., & Phillips, R. S. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31829ae38d · Cited by 65
Schüetz, P., RAAD, I. I., & Amin, D. (2013) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328363bd38 · Cited by 65
Serum procalcitonin as a diagnostic biomarker for sepsis in burned patients: A meta-analysis
Ren, H., Li, Y., Han, C., & Hu, H. (2015) · Burns · doi:10.1016/j.burns.2014.08.019 · Cited by 64
Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us
Zhang, Y. Z., & Singh, S. (2015) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v4.i1.13 · Cited by 62
Use of procalcitonin for the prediction and treatment of acute bacterial infection in children
Pierce, R. W., Bigham, M. T., & Giuliano, J. S. (2014) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000092 · Cited by 54
Harrison, M., & Collins, C. D. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2014.60 · Cited by 47
Procalcitonin as a Marker of Severe Bacterial Infection in Children in the Emergency Department
Deis, J. N., Creech, C. B., Estrada, C. M., & Abramo, T. J. (2010) · Pediatric Emergency Care · doi:10.1097/pec.0b013e3181c399df · Cited by 44
Magrini, L., Travaglino, F., Marino, R., Ferri, E., Berardinis, B. D., Cardelli, P., Salerno, G., & Somma, S. D. (2013) · PubMed · Cited by 43
Use of Serum Procalcitonin in Evaluation of Febrile Infants: A Meta-analysis of 2317 Patients
England, J. T., Vecchio, M. T. D., & Aronoff, S. C. (2014) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2014.07.034 · Cited by 40
Zhao, Y., Li, C.-S., & Jia, Y. (2013) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2013.04.008 · Cited by 36
Butler, A. E., Canamucio, A., Macpherson, D. S., Skoko, J. E., & True, G. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2668-x · Cited by 29
Lack of Transferability of Results between Procalcitonin Assays
García, B. P., & Álvarez, F. V. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.132605 · Cited by 9
Ingram, N. (2013) · Journal of the Intensive Care Society · doi:10.1177/175114371301400310 · Cited by 5
Research works printed but not linked: 2
- Snider, 1997, Procalcitonin and its component peptides in systemic inflammation: immunochemical characterisation, J Investig Med, 45, 552
- Lloyd, 2012, Comparison of three methods for procalcitonin analysis, Med Technol SA, 26, 48
Cited by
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
Yunus, I., Fasih, A., & Wang, Y. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206527 · Cited by 118
Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis
Cong, S., Ma, T., Di, X., Tian, C., Zhao, M., & Wang, K. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06064-0 · Cited by 98
Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
“In these conditions, the level of procalcitonin is decreased in the body [20].”
BackgroundGao, L., Liu, X., Zhang, D., Xu, F., Chen, Q., Ye, H., Feng, G., Shi, Q., Yang, B., & Xu, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4417 · Cited by 61
Metadata
- Authors
- Davies, J.
- Affiliations
- Wye Valley NHS Trust (GB)
- Corresponding author
- Davies, Julie
- ORCID
- Davies, Julie
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 2015-06-29
- Volume
- 68
- Issue
- 9
- Pages
- 675-679
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- OpenAlex
- W4253354731
- Cited by
- 135
- References
- 48
- Citations by year
- 2026: 7 · 2025: 21 · 2024: 10 · 2023: 9 · 2022: 18 · 2021: 13 · 2020: 17 · 2019: 7 · 2018: 9 · 2017: 13 · 2016: 8 · 2015: 2
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Pathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- procalcitonin, calcitonin, bacterial infection, viral infection, antibiotic resistance, antibiotic stewardship, infection diagnosis, cost-effectiveness, primary care, emergency department, intensive care unit
- MeSH terms
- Animals, Bacterial Infections, Calcitonin, Drug Resistance, Microbial, Humans, Protein Precursors, Biomarkers, Calcitonin Gene-Related Peptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.